• Responsible for providing strategic leadership and planning for the Company's Medical Education programs• Overseeing $13M budget and team of 12 for the group's conception, organization, and execution of cadaveric workshops and all other Medical Education engagements to grow new surgeon advocates• Helping with strategic alignment between Medical Education, Sales & Product teams• Creating a culture connecting outputs to results, with an emphasis on clear, concise and consistent communication, focusing on elite execution to grow the brand• Training new surgeons on existing products as well as preparing to train all surgeons on new product launches

Drive performance for MagStim TMS for depression, EGI high density EEG, Technomed clinical neurophysiology and Neurosign nerve Monitoring, totaling $55m for 2023 budget• Overhauled compensation plan to incentivize more profitable selling strategies• Craft two new indication launch plans for 2023• Streamline product portfolio to sunset less profitable lines and emphasize higher margins• Create forecasting dashboards to inform leadership of deal flow• Develop and present strategic sales plans to board of directors and executive leadership• Crafted international distributor plan with EGI team to drive business• Optimize administration obligations on team to generate more selling time• Significant need for personnel retention in a change heavy environment• Improve strategies for marketing, training, customer support, technical support, and operations• Prioritize necessary tradeshows and collateral for marketing• Construct pathway to cross pollinate customers to grow all businesses

Head of US sales, growing both Micromed and Moberg lines of business in major hospital systems• Build robust sales pipeline, manage development and performance of sales team, and design compensation to incentivize growth• Lead strategies for marketing, KOL development, customer support, technical support, and operations• Develop and present strategic sales plans to board of directors and executive leadership• Significant role in streamlining operations, personnel retention and shaping strategic direction of Micromed U.S.• Created new, highest margin revenue stream through software maintenance packages for Moberg business line. Pipeline of $450,000 in year one. Tracking to $800,000 year two.• Closed largest revenue and unit opportunity in Moberg history, at $1.971m in July 2022• U.S. business currently at 93% to plan for 2022. Target finish of 116%-125%• Pipeline of $5m in place for 2023 as of October 2022

Enhance overall brand strategy, messaging with additional focus on training, E-Commerce strategy and Digital optimization. Working with internal and external partners, we created enhanced training experiences for partner stores and distributors to communicate the KOHA value proposition for all levels of retail partners.

• Led company’s highest revenue ($360M), most profitable (90%+ margin) Neuromodulation business, as well as Cardiac Rhythm Management—US, & Cardiac Surgery; hired, mentored, created actionable strategies, and reduced constraints for as many as 45 leaders• Led most successful product launch in company history with VNS Therapy’s SenTiva device, overachieving first quarter launch by 40% and first year’s projections by 38%• Identified growth areas and led change initiatives to seize opportunities e.g. data-driven targeting and segmentation initiative to grow new business and direct-to-consumer initiative• Overhauled education approach, e.g. physician/patient, peer-to-peer, and symposium structure• Led critical initiative to track $9M+ budget, gathering data analytics to improve decision-making• Focused organization on consumer data/needs and direct-to-consumer advertising, spearheading company’s first direct-to-consumer advertising campaign with 2018 $10M budget• Partnered with Product Development and Market Development on R&D to develop right strategy, products/features, and messaging; ensured products/features met needs of physicians and patients• Primary role on M&A opportunities, from front-end due diligence through implementation• Defined and implemented digital transformation strategy, e.g. website capabilities, patient and provider education content, collective digital information platform, and optimized digital messaging

Develop and implement plan and strategy for VNS therapy in order to continue to grow top and bottom line for the Neuromodulation Division. Creating resources and opportunities Upstream and Downstream to support brand growth. Key initial goal of strengthening our digital presence for entire portfolio of product line, including web site reconstruction, all sales materials as well as all patient support documentation. In charge of Sales Training as well as direct input on New Business Opportunities.

Cyberonics is a proven neuromodulation leader with our VNS therapy system for refractory epilepsy and treatment resistant depression. VNS therapy uses a surgically implanted pulse generator that delivers electric stimulation to the vagus nerve, improving seizure control. I currently lead a team of 10 therapeutic consultants 2 clinical specialists and 2 OR specialists. We sell to hospitals through demand creation, working with neurologists, neurosurgeons, vascular surgeons, ENT and General surgeons. We strategize and negotiate with purchasing managers and hospital CFOs to arrange for product buys. Responsible for sourcing, hiring and retaining a diverse sales team, provide coaching, guidance for growth and work on personal/career development. Annual regional revenues of approximately $24 million. 5 year regional sales growth of nearly 100%.Geography covers much or all of Florida, Georgia, Alabama and parts of Mississippi and Louisiana. Cross functional leadership including strong interaction with sales operations (sales goals and alignments), marketing (craft message), senior management (business results), customer support and human resources. Extensive experience launching new products, including Demipulse generator, Aspire HC and Aspire SR with strong conversion rates.

Grow sales of VNS inside of large academic institutions such as NYU, Columbia, LIJ, Cornell, Hackensack University Medical Center and Westchester Medical Center. Partnered with physicians and surgeons to identify appropriate VNS candidates.Second territory in company to achieve $1 million in quarterly revenue. Consistent high achiever, developing neurology and surgery relationships across New York City, Long Island, New Jersey, Connecticut, Westchester.

Responsible for driving business results while growing and retaining top talent

Improve skill set of new and experience territory representatives by conducting field rides, training seminars and coaching workshops. Focus on improving message, skill set and ultimately business results.

Working with 3 counterparts to grow market share for Lexapro and Benicar working with psychiatrists, cardiologists and internal medicine physicians.

Selling Celexa & Tiazac to Psychiatrists, internal medicine physicians and cardiologists.

Selling, consulting and growing enrollment with accounts like Pfizer, General Motors and American Express. Conducted educational seminars to educate consumer as well as account contacts.